One-Compartment Open Model for IV Bolus Administration: General Considerations

In the one-compartment open model, 'open' signifies unidirectional drug input and output processes. The body is viewed as a single, homogenous compartment where drugs dynamically traverse and assume rapid equilibrium between plasma and other body fluids. This contrasts with closed systems where drugs cannot leave the body.

Elimination follows a first-order process with a consistent rate constant, meaning the rate of drug elimination is proportional to the drug concentration present. The rate of drug presentation to the body is defined by an equation representing the difference between the rate of drug entry and exit, allowing prediction of drug concentration over time.

Plasma serves as the reference compartment because plasma drug concentration change is proportional to tissue drug concentration changes. This relationship assumes rapid equilibrium between plasma and other body fluids, allowing plasma measurements to reflect overall drug distribution and elimination throughout the body.

Key parameters include the elimination rate constant, half-life, apparent volume of distribution, and total systemic clearance. These parameters can be calculated directly from the plasma concentration-time profile or by using non-compartmental methods, providing essential information for safe and effective dosing.

The one-compartment open model is ideal for rapidly dispersing drugs that are quickly and completely absorbed, such as intravenous bolus-administered theophylline and propofol. These drugs distribute rapidly throughout the body and follow first-order elimination kinetics, making them suitable for this simplified modeling approach.

The residuals method separates the plasma concentration-time curve into absorption and elimination phases to determine the absorption rate constant. This approach is particularly useful for extravascular administration, where distinguishing between absorption and elimination phases is necessary for accurate pharmacokinetic parameter estimation.

Lag time represents the interval between drug administration and absorption onset, delaying the appearance of drug in plasma. The model accounts for this delay, and a bi-exponential equation can define the resulting plasma concentration-time profile, ensuring accurate predictions of drug kinetics when absorption is not instantaneous.